Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Letavic

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Topics in Medicinal Chemistry|August 5, 2008
Histamine H3 antagonists as wake-promoting and pro-cognitive agentsEmily M Stocking, Michael A Letavic
Progress in Medicinal Chemistry|May 5, 2020
P2X7 receptor antagonists for the treatment of systemic inflammatory disordersChristine F Gelin, Anindya Bhattacharya, Michael A Letavic
Current Topics in Medicinal Chemistry|February 20, 2010
Exploration of structure-activity relationships for dual serotonin transporter reuptake inhibitors-histamine H3 receptor antagonistsEmily M Stocking, Michael A Letavic, Pascal Bonaventure, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2016
The evolution of P2X7 antagonists with a focus on CNS indicationsJason C Rech, Anindya Bhattacharya, Michael A Letavic, et al.
Progress in Medicinal Chemistry|January 15, 2014
P2X7 antagonists as potential therapeutic agents for the treatment of CNS disordersChrista C Chrovian, Jason C Rech, Anindya Bhattacharya, et al.
Progress in Medicinal Chemistry|May 16, 2006
Recent medicinal chemistry of the histamine H3 receptorMichael A Letavic, Ann J Barbier, Curt A Dvorak, et al.
Plos One|June 10, 2016
Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure ModelsWolfgang Fischer, Heike Franke, Ute Krügel, et al.
Frontiers in Behavioral Neuroscience|May 24, 2017
Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in MiceSujin Yun, Michelle Wennerholm, Jonathan E Shelton, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor AntagonistsBrad M Savall, Duncan Wu, Meri De Angelis, et al.
Psychopharmacology|May 23, 2012
Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboonJean Logan, Nicholas I Carruthers, Michael A Letavic, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Topics in Medicinal Chemistry|August 5, 2008
Histamine H3 antagonists as wake-promoting and pro-cognitive agentsEmily M Stocking, Michael A Letavic
Progress in Medicinal Chemistry|May 5, 2020
P2X7 receptor antagonists for the treatment of systemic inflammatory disordersChristine F Gelin, Anindya Bhattacharya, Michael A Letavic
Current Topics in Medicinal Chemistry|February 20, 2010
Exploration of structure-activity relationships for dual serotonin transporter reuptake inhibitors-histamine H3 receptor antagonistsEmily M Stocking, Michael A Letavic, Pascal Bonaventure, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2016
The evolution of P2X7 antagonists with a focus on CNS indicationsJason C Rech, Anindya Bhattacharya, Michael A Letavic, et al.
Progress in Medicinal Chemistry|January 15, 2014
P2X7 antagonists as potential therapeutic agents for the treatment of CNS disordersChrista C Chrovian, Jason C Rech, Anindya Bhattacharya, et al.
Progress in Medicinal Chemistry|May 16, 2006
Recent medicinal chemistry of the histamine H3 receptorMichael A Letavic, Ann J Barbier, Curt A Dvorak, et al.
Plos One|June 10, 2016
Critical Evaluation of P2X7 Receptor Antagonists in Selected Seizure ModelsWolfgang Fischer, Heike Franke, Ute Krügel, et al.
Frontiers in Behavioral Neuroscience|May 24, 2017
Selective Inhibition of Orexin-2 Receptors Prevents Stress-Induced ACTH Release in MiceSujin Yun, Michelle Wennerholm, Jonathan E Shelton, et al.
ACS Medicinal Chemistry Letters|June 24, 2015
Synthesis, SAR, and Pharmacological Characterization of Brain Penetrant P2X7 Receptor AntagonistsBrad M Savall, Duncan Wu, Meri De Angelis, et al.
Psychopharmacology|May 23, 2012
Blockade of the brain histamine H3 receptor by JNJ-39220675: preclinical PET studies with [¹¹C]GSK189254 in anesthetized baboonJean Logan, Nicholas I Carruthers, Michael A Letavic, et al.
Pageof 6